Polyrizon Ltd. (PLRZ)

Market Cap	21.21M +246.1%
Revenue (ttm)	n/a
Net Income	-3.34M
EPS	-4.90
Shares Out	1.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,404
Open	11.24
Previous Close	11.59
Day's Range	11.00 - 11.59
52-Week Range	2.88 - 18.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2026

About PLRZ

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Oct 29, 2024
• Employees: 4
• Stock Exchange: NASDAQ
• Ticker Symbol: PLRZ
• Website: https://www.polyrizon-biotech.com

Financial Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 10, 2026

Data Sources Report a data error